Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

The influence of obesity on the disease-free survival in primary breast cancer.

Obermair A, Kurz C, Hanzal E, Bancher-Todesca D, Thoma M, Bodisch A, Kubista E, Kyral E, Kaider A, Sevelda P, et al.

Anticancer Res. 1995 Sep-Oct;15(5B):2265-9.

PMID:
8572635
2.

Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.

Willner J, Kiricuta IC, Kölbl O.

Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):853-63.

PMID:
9128962
3.

LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.

Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.

Anticancer Res. 2004 Jul-Aug;24(4):2391-400.

4.

Obesity at diagnosis of breast carcinoma influences duration of disease-free survival.

Senie RT, Rosen PP, Rhodes P, Lesser ML, Kinne DW.

Ann Intern Med. 1992 Jan 1;116(1):26-32.

PMID:
1727092
5.

Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.

Dignam JJ, Wieand K, Johnson KA, Raich P, Anderson SJ, Somkin C, Wickerham DL.

Breast Cancer Res Treat. 2006 Jun;97(3):245-54. Epub 2005 Dec 6.

PMID:
16331345
6.

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.

Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pène F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38.

PMID:
9989511
7.

Prognostic significance of local recurrence in breast cancer after postmastectomy radiotherapy.

Dunst J, Steil B, Furch S, Fach A, Lautenschläger C, Diestelhorst A, Lampe D, Kölbl H, Richter C.

Strahlenther Onkol. 2001 Oct;177(10):504-10.

PMID:
11680014
8.

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Epub 2007 Aug 9. Review.

PMID:
17687650
9.

Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.

Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.

Jpn J Clin Oncol. 2005 Mar;35(3):126-33.

PMID:
15741302
10.

Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy.

Dinshaw KA, Budrukkar AN, Chinoy RF, Sarin R, Badwe R, Hawaldar R, Shrivastava SK.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1132-41. Epub 2005 Jun 22.

PMID:
15978744
11.

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

Diel IJ, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, Kaul S, Bastert G.

J Natl Cancer Inst. 1996 Nov 20;88(22):1652-8.

PMID:
8931609
12.

Is obesity an independent prognosis factor in woman breast cancer?

Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B.

Breast Cancer Res Treat. 2008 Sep;111(2):329-42. Epub 2007 Oct 16.

PMID:
17939036
13.

Prognostic significance of young age in breast cancer.

Yildirim E, Dalgiç T, Berberoğlu U.

J Surg Oncol. 2000 Aug;74(4):267-72.

PMID:
10962458
14.

Obesity and outcomes in premenopausal and postmenopausal breast cancer.

Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, Hopper JL, Phillips KA.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1686-91.

15.

S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.

Gazic B, Pizem J, Bracko M, Cufer T, Borstnar S, Pohar-Marinsek Z, Us-Krasovec M.

Cytopathology. 2008 Oct;19(5):294-302. Epub 2007 Dec 7.

PMID:
18070112
16.

Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.

Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR, Hellman S.

J Natl Cancer Inst. 1996 Dec 4;88(23):1764-9.

PMID:
8944007
17.

Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L.

Thomssen C, Oppelt P, Jänicke F, Ulm K, Harbeck N, Höfler H, Kuhn W, Graeff H, Schmitt M.

Anticancer Res. 1998 May-Jun;18(3C):2173-80.

PMID:
9703780
18.

Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.

Shen J, Hunt KK, Mirza NQ, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Ross MI, Ames FC, Feig BW, Singletary SE, Cristofanilli M, Meric-Bernstam F.

Cancer. 2005 Aug 1;104(3):479-90.

19.

Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.

Fisher BJ, Perera FE, Cooke AL, Opeitum A, Venkatesan V, Dar AR, Stitt L.

Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):541-50.

PMID:
9231678
20.

[Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].

Guan Y, Xu BH, Li Q, Zhang P, Zhao LM, Yuan P, Wang JY.

Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):77-81. Chinese.

PMID:
18353207

Supplemental Content

Support Center